Mechanisms of Resistance to the FLT3-Tyrosine Kinase Inhibitor PKC412 in Patients with AML.
暂无分享，去创建一个
E. Estey | D. DeAngelo | R. Stone | S. Nimer | F. Giles | F. Breitenbuecher | F. Heidel | C. Huber | T. Fischer | G. Ehninger | G. Schiller | E. Feldman | T. Kindler | V. Klimek | P. Cohen | J. Roesel | F. Solem | H. Thiede | Birgit Carius